This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effective treatment of breast cancer: A Synthesis of Findings from 143 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of breast cancer: A Synthesis of Findings from 143 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

The combination of conservation surgery and radiation therapy for early breast cancer is gaining acceptance as an alternative to radical mastectomy. 48 This article reviews the results of randomized trials showing that there is no advantage to a radical mastectomy in patients with early breast cancer. 48 In addition, the article will review multiple reports concerning the local and regional tumor control and survival of patients treated with conservation surgery and irradiation as well as a comparison of 1073 patients with TIS T1 T2 N0 N1 breast cancer treated at University of Texas (UT) M. D. Anderson Hospital between 1955 and 1980, of whom 345 were treated with conservation surgery and irradiation and 728 were treated with radical or modified radical mastectomy alone. The locoregional recurrence in the patients treated with an intact breast is 4.9%, and 5.6% in patients treated with radical or modified radical mastectomy. There is no significant difference in the 10-year disease-free survival rates between the two groups of patients. In addition, a comparison of 2467 patients with Stage I and Stage II breast cancer treated at the UT M. D. Anderson Hospital shows no significant difference in the incidence of consecutive second breast carcinoma as a result of the use of radiation therapy in the treatment of the first breast cancer.

Adjuvant systemic treatment for resectable breast cancer changes the natural history of the disease but provides only a small and delayed effect on survival. 61 Evaluation of the types of first relapse avoided by available treatments may explain why effects on mortality are small and appear late during follow-up. In randomised clinical trials done by the International Breast Cancer Study Group (IBCSG) between 1978 and 1985, 2108 patients with node-positive disease received more-effective treatments (6 or more cycles of cyclophosphamide, methotrexate, fluorouracil and prednisone; with or without tamoxifen, or tamoxifen and prednisone alone), and 722 patients received less-effective treatments (no treatment or a single cycle of chemotherapy). 3 main categories of first site of relapse were defined and evaluated by cumulative incidence analysis: local or regional, and distant soft tissue, bone, and viscera. The more-effective treatments reduced the cumulative incidence of first relapse in local or regional and distant soft tissue sites at 10 years from 36% to 18% (p = 0.0001); first relapse in bone and viscera was not altered by the more-effective treatments. These results were similar for premenopausal and postmenopausal women, and for patients with oestrogen-receptor-positive or oestrogen-receptor-negative tumours. Adjuvant systemic treatments in current use improve patient outcome mainly by reducing the incidence of first local or regional and distant soft-tissue relapses, while first recurrences in bone or viscera are influenced much less. More intensive treatments at present being tested in clinical trials might affect bone and visceral relapses and have a greater and earlier influence on survival.

Seventy patients with breast cancer (stage IIIb--IV) were randomized by an "envelope" method into 2 groups, each including 35 persons. 3 Patients of the first group were injected vincristin, 5-fluoruracil, methotrexate (once a week), cyclophosphane (3 times a week) and prednisolone daily during 3 weeks. The duration of the course of treatment was 4 weeks. The therapy course was repeated with an interval of 1--2 months. Patients of the second group in addition to the analogous treatment were subjected to ovariectomy with subsequent continuous administration of prednisolone, testosterone-propionate or synoestrol. An objective effect was noted in 24 patients of the first group (71.4%), the complete remission being gained in 4 of them. An average duration of the remission--7.6 months. An objective effect was noted in 31 patients of the second group (88.5%), the complete remission--in 4 of them. An average duration of the remission--10.7 months. Primary mammary tumors and metastases in regional lymph nodes proved to be mostly susceptible to the conducted therapy. Lung and pleural metastases were found to be less susceptible. No grave complications due to this kind of treatment were noted.

Treatment Summary

The combination of conservation surgery and radiation therapy is a viable alternative to radical mastectomy for early stage breast cancer patients. 48 In addition, effective adjuvant systemic treatments, such as chemotherapy, have been shown to reduce the risk of relapse, particularly in the local or regional areas and distant soft tissue. 61 For advanced stages of breast cancer (Stage IIIb-IV), combined drug treatment, including vincristin, 5-fluorouracil, methotrexate, cyclophosphane, and prednisolone, can be effective. 3

Benefits and Risks

Benefit Summary

Conservation surgery and radiation therapy offer a less invasive treatment option compared to radical mastectomy, potentially leading to better cosmetic outcomes and reduced physical and psychological burden for patients. 48 Adjuvant systemic treatments, particularly chemotherapy, can effectively reduce the risk of recurrence, especially for local, regional, and distant soft tissue relapse. 61

Risk Summary

Radiation therapy carries the risk of long-term effects on the heart and lungs. 94 Chemotherapy can cause various side effects such as bone marrow suppression, gastrointestinal issues, cystitis, and hair loss. 36

Comparison of Studies

Commonalities of Studies

Multiple studies consistently demonstrate the effectiveness of conservation surgery and radiation therapy as an alternative to radical mastectomy for early-stage breast cancer. Additionally, they emphasize the importance of adjuvant systemic treatments, particularly chemotherapy, in reducing the risk of recurrence.

Differences in Studies

48 primarily focuses on comparing the effectiveness of conservation surgery and radiation therapy with radical mastectomy, while 61 analyzes the impact of chemotherapy on different relapse sites. 36 investigates the efficacy of combining chemotherapy and hormone therapy for breast cancer.

Consistency and Contradictions of Results

While various studies confirm the benefits of conservation surgery with radiation therapy and adjuvant chemotherapy, they also highlight the potential risks associated with these treatments. Radiation therapy can impact the heart and lungs, and chemotherapy can cause side effects. 94 36

Implications for Real-Life Applications

For early breast cancer patients, conservation surgery and radiation therapy, along with adjuvant chemotherapy, can be effective treatment options. 94 36 However, it is crucial to consider the potential risks and discuss them with your doctor to make informed decisions about your treatment plan.

Limitations of Current Research

Many studies involve relatively small sample sizes, raising concerns about the generalizability of their findings. Additionally, some studies require long-term follow-up, so their results are not yet fully available.

Future Directions for Research

Large-scale clinical trials with larger patient populations are needed to validate the findings of existing studies. Furthermore, continued research is essential to better understand the long-term effects and side effects of breast cancer treatments.

Conclusion

Conservation surgery with radiation therapy and adjuvant chemotherapy are valuable treatment options for early breast cancer patients. 94 36 However, it is essential to consider the potential risks and discuss them with your doctor to make informed decisions about your treatment plan. Future research will hopefully lead to the development of even more effective and safer treatment options for breast cancer.

List of Treatments

Conservation surgery, radiation therapy, chemotherapy, hormone therapy, tamoxifen, cyclophosphamide, methotrexate, fluorouracil, prednisone, vincristin, 5-fluorouracil, cyclophosphane, mitomycin C, thiotepa, vindesine, epirubicin, vincristine, paclitaxel, docetaxel


Keywords
Benefit Keywords
Risk Keywords
Literature analysis of 143 papers
Positive Content
132
Neutral Content
10
Negative Content
1
Article Type
99
29
30
31
141

Language : English


Language : English


Language : Russian


Language : English


Language : English


Language : English


Language : German


Language : English


Language : English


Language : English


Language : Russian


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : French


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : French


Language : Russian


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : Japanese


Language : German


Language : English


Language : English


Language : English


Language : English


Language : German


Language : English


Language : English


Language : Danish


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : German


Language : English


Language : Italian


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : Russian


Language : French


Language : German


Language : English


Language : German


Language : English


Language : French


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : Spanish


Author: MartínMiguel, Rodríguez-LescureAlvaro, RuizAmparo, AlbaEmilio, CalvoLourdes, Ruiz-BorregoManuel, MunárrizBlanca, RodríguezCésar A, CrespoCarmen, de AlavaEnrique, López García-AsenjoJosé Antonio, GuitiánMaría Dolores, AlmenarSergio, González-PalaciosJesús Fernando, VeraFrancisco, PalaciosJosé, RamosManuel, Gracia MarcoJose Manuel, LluchAna, AlvarezIsabel, SeguíMiguel Angel, MayordomoJosé Ignacio, AntónAntonio, BaenaJosé Manuel, PlazaolaArrate, ModolellAlfonso, PelegríAmadeu, MelJose Ramón, ArandaEnrique, AdroverEncarna, AlvarezJosé Valero, García PucheJosé Luis, Sánchez-RoviraPedro, GonzalezSonia, López-VegaJosé Manuel,


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Author: HurvitzSara A, MartinMiguel, SymmansW Fraser, JungKyung Hae, HuangChiun-Sheng, ThompsonAlastair M, HarbeckNadia, ValeroVicente, StroyakovskiyDaniil, WildiersHans, CamponeMario, BoileauJean-François, BeckmannMatthias W, AfenjarKaren, FrescoRodrigo, HelmsHans-Joachim, XuJin, LinYvonne G, SparanoJoseph, SlamonDennis


Language : English


Language : English


Author: SchochterFabienne, RackBrigitte, TzschaschelMarie, PolasikArkadius, AndergassenUlrich, TrappElisabeth, Alunni-FabbroniMarianna, SchneeweissAndreas, MüllerVolkmar, PantelKlaus, GadeJörg, LorenzRalf, RezaiMahdi, TeschHans, SoelingUlrike, FehmTanja, MahnerSven, SchindlbeckChristian, LichteneggerWerner, BeckmannMatthias W, FaschingPeter A, JanniWolfgang, FriedlThomas W P,


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Author: SchneiderBryan P, JiangGuanglong, BallingerTarah J, ShenFei, ChitambarChristopher, NandaRita, FalksonCarla, LynceFilipa C, GallagherChristopher, IsaacsClaudine, BlayaMarcelo, PaplomataElisavet, WallingRadhika, DailyKaren, MahtaniReshma, ThompsonMichael A, GrahamRobert, CooperMaureen E, PavlickDean C, AlbackerLee A, GreggJeffrey, SolzakJeffrey P, ChenYu-Hsiang, BalesCasey L, CantorErica, HancockBradley A, KassemNawal, HelftPaul, O'NeilBert, StornioloAnna Maria V, BadveSunil, MillerKathy D, RadovichMilan


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.